Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Kieff, E' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 83 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Lin, J; Johannsen, E; Robertson, E; Kieff, E
      Epstein-Barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2

      JOURNAL OF VIROLOGY
    2. Higuchi, M; Kieff, E; Izumi, KM
      The Epstein-Barr virus latent membrane protein 1 putative Janus kinase 3 (JAK3) binding domain does not mediate JAK3 association or activation in B-lymphoma or lymphoblastoid cell lines

      JOURNAL OF VIROLOGY
    3. Higuchi, M; Izumi, KM; Kieff, E
      Epstein-Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: Protein 1 binds to the cytoskeleton through TNF receptorcytoplasmic factors

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    4. Hung, SC; Kang, MS; Kieff, E
      Maintenance of Epstein-Barr virus (EBV) oriP-based episomes requires EBV-encoded nuclear antigen-1 chromosome-binding domains, which can be replaced by high-mobility group-I or histone H1

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    5. Han, I; Harada, S; Weaver, D; Xue, Y; Lane, W; Orstavik, S; Skalhegg, B; Kieff, E
      EBNA-LP associates with cellular proteins including DNA-PK and HA95

      JOURNAL OF VIROLOGY
    6. Harada, S; Yalamanchili, R; Kieff, E
      Epstein-Barr virus nuclear protein 2 has at least two N-terminal domains that mediate self-association

      JOURNAL OF VIROLOGY
    7. Luftig, MA; Cahir-McFarland, E; Mosialos, G; Kieff, E
      Effects of the NIK aly mutation on NF-kappa B activation by the Epstein-Barr virus latent infection membrane protein, lymphotoxin beta receptor, and CD40

      JOURNAL OF BIOLOGICAL CHEMISTRY
    8. Callahan, J; Aster, J; Sklar, J; Kieff, E; Robertson, ES
      Intracellular forms of human NOTCH1 interact at distinctly different levels with RBP-Jkappa in human B and T cells

      LEUKEMIA
    9. Orstavik, S; Eide, T; Collas, P; Han, IO; Tasken, K; Kieff, E; Jahnsen, T; Skalhegg, BS
      Identification, cloning and characterization of a novel nuclear protein, HA95, homologous to A-kinase anchoring protein 95

      BIOLOGY OF THE CELL
    10. Sylla, BS; Murphy, K; Cahir-McFarland, E; Lane, WS; Mosialos, G; Kieff, E
      The X-linked lymphoproliferative syndrome gene product SH2D1A associates with p62(dok) (Dok1) and activates NF-kappa B

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    11. Cahir-McFarland, ED; Davidson, DM; Schauer, SL; Duong, J; Kieff, E
      NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    12. Wang, L; Grossman, SR; Kieff, E
      Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    13. Baron, S; Poast, J; Rizzo, D; McFarland, E; Kieff, E
      Electroporation of antibodies, DNA, and other macromolecules into cells: ahighly efficient method

      JOURNAL OF IMMUNOLOGICAL METHODS
    14. Ye, H; Park, YC; Kreishman, M; Kieff, E; Wu, H
      The structural basis for the recognition of diverse receptor sequences by TRAF2

      MOLECULAR CELL
    15. Paya, CV; Fung, JJ; Nalesnik, MA; Kieff, E; Green, M; Gores, G; Habermann, TM; Wiesner, RH; Swinnen, LJ; Woodle, ES; Bromberg, JS
      Epstein-Barr virus-induced, posttransplant lymphoproliferative disorders

      TRANSPLANTATION
    16. Lee, H; Choi, JK; Li, MT; Kaye, K; Kieff, E; Jung, JU
      Role of cellular tumor necrosis factor receptor-associated factors in NF-kappa B activation and lymphocyte transformation by herpesvirus Saimiri STP

      JOURNAL OF VIROLOGY
    17. Kube, D; Vockerodt, M; Weber, O; Hell, K; Wolf, J; Haier, B; Grasser, FA; Muller-Lantzsch, N; Kieff, E; Diehl, V; Tesch, H
      Expression of Epstein-Barr virus nuclear antigen 1 is associated with enhanced expression of CD25 in the Hodgkin cell line L428

      JOURNAL OF VIROLOGY
    18. Izumi, KM; McFarland, EC; Riley, EA; Rizzo, D; Chen, YZ; Kieff, E
      The residues between the two transformation effector sites of Epstein-Barrvirus latent membrane protein 1 are not critical for B-lymphocyte growth transformation

      JOURNAL OF VIROLOGY
    19. Kaye, KM; Izumi, KM; Li, H; Johannsen, E; Davidson, D; Longnecker, R; Kieff, E
      An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformation

      JOURNAL OF VIROLOGY
    20. KIEFF E
      FIELDS,BERNARD,N. - 1938-1995 - IN-MEMORIAM

      Proceedings of the Association of American Physicians
    21. SADELAIN M; KIEFF E
      WHY COMMONPLACE ENCOUNTERS TURN TO FATAL ATTRACTION

      Nature genetics
    22. Kieff, E; Shenk, T
      Modulation of apoptosis by herpesviruses

      SEMINARS IN VIROLOGY
    23. SYLLA BS; HUNG SC; DAVIDSON DM; HATZIVASSILIOU E; MALININ NL; WALLACH D; GILMORE TD; KIEFF E; MOSIALOS G
      EPSTEIN-BARR-VIRUS-TRANSFORMING PROTEIN LATENT INFECTION MEMBRANE-PROTEIN-1 ACTIVATES TRANSCRIPTION FACTOR NF-KAPPA-B THROUGH A PATHWAY THAT INCLUDES THE NF-KAPPA-B-INDUCING KINASE AND THE I-KAPPA-B KINASES IKK-ALPHA AND IKK-BETA

      Proceedings of the National Academy of Sciences of the United Statesof America
    24. HARADA S; YALAMANCHILI R; KIEFF E
      RESIDUE-231 TO RESIDUE-280 OF THE EPSTEIN-BARR-VIRUS NUCLEAR-PROTEIN-2 ARE NOT ESSENTIAL FOR PRIMARY B-LYMPHOCYTE GROWTH TRANSFORMATION

      Journal of virology (Print)
    25. DEVERGNE O; MCFARLAND EC; MOSIALOS G; IZUMI KM; WARE CF; KIEFF E
      ROLE OF THE TRAF BINDING-SITE AND NF-KAPPA-B ACTIVATION IN EPSTEIN-BARR-VIRUS LATENT MEMBRANE-PROTEIN 1-INDUCED CELL GENE-EXPRESSION

      Journal of virology
    26. HATZIVASSILIOU E; MILLER WE; RAABTRAUB N; KIEFF E; MOSIALOS G
      FUSION OF THE EBV LATENT MEMBRANE PROTEIN-1 (LMP1) TRANSMEMBRANE DOMAINS TO THE CD40 CYTOPLASMIC DOMAIN IS SIMILAR TO LMP1 IN CONSTITUTIVE ACTIVATION OF EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION, NUCLEAR FACTOR-KAPPA-B, AND STRESS-ACTIVATED PROTEIN-KINASE

      The Journal of immunology
    27. KIEFF E
      VIRAL PATHOGENESIS OF AIDS-RELATED MALIGNANCIES

      Journal of acquired immune deficiency syndromes and human retrovirology
    28. ROCHFORD R; MILLER CL; CANNON MJ; IZUMI KM; KIEFF E; LONGNECKER R
      IN-VIVO GROWTH OF EPSTEIN-BARR-VIRUS TRANSFORMED B-CELLS WITH MUTATIONS IN LATENT-MEMBRANE-PROTEIN-2 (LMP2)

      Archives of virology
    29. INOUE J; ISHIDA T; WATANABE T; MOSIALOS G; KIEFF E; YAMAMOTO T
      TRAF5 AND TRAF6 MEDIATE CD4O SIGNALING

      Journal of allergy and clinical immunology
    30. VANARSDALE TL; VANARSDALE SL; FORCE WR; WALTER BN; MOSIALOS G; KIEFF E; REED JC; WARE CF
      LYMPHOTOXIN-BETA RECEPTOR SIGNALING COMPLEX - ROLE OF TUMOR-NECROSIS-FACTOR RECEPTOR-ASSOCIATED FACTOR 3 RECRUITMENT IN CELL-DEATH AND ACTIVATION OF NUCLEAR FACTOR KAPPA-B

      Proceedings of the National Academy of Sciences of the United Statesof America
    31. ANSIEAU S; SCHEFFRAHN I; MOSIALOS G; BRAND H; DUYSTER J; KAYE K; HARADA J; DOUGALL B; HUBINGER G; KIEFF E; HERRMANN F; LEUTZ A; GRUSS HJ
      TUMOR-NECROSIS-FACTOR RECEPTOR-ASSOCIATED FACTOR (TRAF)-1, TRAF-2, AND TRAF-3 INTERACT IN-VIVO WITH THE CD30 CYTOPLASMIC DOMAIN - TRAF-2 MEDIATES CD30-INDUCED NUCLEAR FACTOR KAPPA-B ACTIVATION (RETRACTION OF VOL 93, PG 14053, 1996)

      Proceedings of the National Academy of Sciences of the United Statesof America
    32. DEVERGNE O; BIRKENBACH M; KIEFF E
      EPSTEIN-BARR VIRUS-INDUCED GENE-3 AND THE P35 SUBUNIT OF INTERLEUKIN-12 FORM A NOVEL HETERODIMERIC HEMATOPOIETIN

      Proceedings of the National Academy of Sciences of the United Statesof America
    33. CHATILA T; HO N; LIU PT; LIU SF; MOSIALOS G; KIEFF E; SPECK SH
      THE EPSTEIN-BARR VIRUS-INDUCED CA2+ CALMODULIN-DEPENDENT KINASE TYPE IV/GR PROMOTES A CA2+-DEPENDENT SWITCH FROM LATENCY TO VIRAL REPLICATION/

      Journal of virology
    34. HARADA S; KIEFF E
      EPSTEIN-BARR-VIRUS NUCLEAR-PROTEIN LP STIMULATES EBNA-2 ACIDIC DOMAIN-MEDIATED TRANSCRIPTIONAL ACTIVATION

      Journal of virology
    35. MILLER WE; MOSIALOS G; KIEFF E; RAABTRAUB N
      EPSTEIN-BARR-VIRUS LMP1 INDUCTION OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR IS MEDIATED THROUGH A TRAF SIGNALING PATHWAY DISTINCT FROM NF-KAPPA-B ACTIVATION

      Journal of virology
    36. ASTER JC; ROBERTSON ES; HASSERJIAN RP; TURNER JR; KIEFF E; SKLAR J
      ONCOGENIC FORMS OF NOTCH1 LACKING EITHER THE PRIMARY BINDING-SITE FORRBP-J-KAPPA OR NUCLEAR-LOCALIZATION SEQUENCES RETAIN THE ABILITY TO ASSOCIATE WITH RBP-J-KAPPA AND ACTIVATE TRANSCRIPTION

      The Journal of biological chemistry
    37. ELIOPOULOS AG; DAWSON CW; MOSIALOS G; FLOETTMANN JE; ROWE M; ARMITAGE RJ; DAWSON J; ZAPATA JM; KERR DJ; WAKELAM MJO; REED JC; KIEFF E; YOUNG LS
      CD40-INDUCED GROWTH-INHIBITION IN EPITHELIAL-CELLS IS MIMICKED BY EPSTEIN-BARR VIRUS-ENCODED LMP1 - INVOLVEMENT OF TRAF3 AS A COMMON MEDIATOR

      Oncogene
    38. DEVERGNE O; HATZIVASSILIOU E; IZUMI KM; KAYE KM; KLEIJNEN MF; KIEFF E; MOSIALOS G
      ASSOCIATION OF TRAF1, TRAF2, AND TRAF3 WITH AN EPSTEIN-BARR-VIRUS LMP1 DOMAIN IMPORTANT FOR B-LYMPHOCYTE TRANSFORMATION - ROLE IN NF-KAPPA-B ACTIVATION

      Molecular and cellular biology
    39. ANSIEAU S; SCHEFFRAHN I; MOSIALOS G; BRAND H; DUYSTER J; KAYE K; HARADA J; DOUGALL B; HUBINGER G; KIEFF E; HERRMANN F; LEUTZ A; GRUSS HJ
      TUMOR-NECROSIS-FACTOR RECEPTOR-ASSOCIATED FACTOR (TRAF)-1, TRAF-2, AND TRAF-3 INTERACT IN-VIVO WITH THE CD30 CYTOPLASMIC DOMAIN - TRAF-2 MEDIATES CD30-INDUCED NUCLEAR-FACTOR-KAPPA-B ACTIVATION

      Proceedings of the National Academy of Sciences of the United Statesof America
    40. KAYE KM; DEVERGNE O; HARADA JN; IZUMI KM; YALAMANCHILI R; KIEFF E; MOSIALOS G
      TUMOR-NECROSIS-FACTOR RECEPTOR-ASSOCIATED FACTOR-2 IS A MEDIATOR OF NF-KAPPA-B ACTIVATION BY LATENT INFECTION MEMBRANE-PROTEIN-1, THE EPSTEIN-BARR-VIRUS TRANSFORMING PROTEIN

      Proceedings of the National Academy of Sciences of the United Statesof America
    41. JOHANNSEN E; MILLER CL; GROSSMAN SR; KIEFF E
      EBNA-2 AND EBNA-3C EXTENSIVELY AND MUTUALLY EXCLUSIVELY ASSOCIATE WITH RBPJ-KAPPA IN EPSTEIN-BARR VIRUS-TRANSFORMED B-LYMPHOCYTES

      Journal of virology
    42. ROBERTSON ES; LIN J; KIEFF E
      THE AMINO-TERMINAL DOMAINS OF EPSTEIN-BARR-VIRUS NUCLEAR PROTEINS 3A,3B, AND 3C INTERACT WITH RBPJ-KAPPA

      Journal of virology
    43. YALAMANCHILI R; HARADA S; KIEFF E
      THE N-TERMINAL HALF OF EBNA2, EXCEPT FOR 7 PROLINES, IS NOT ESSENTIALFOR PRIMARY B-LYMPHOCYTE GROWTH TRANSFORMATION

      Journal of virology
    44. DEVERGNE O; HUMMEL M; KOEPPEN H; LEBEAU MM; NATHANSON EC; KIEFF E; BIRKENBACH M
      A NOVEL INTERLEUKIN-12 P40-RELATED PROTEIN-INDUCED BY LATENT EPSTEIN-BARR-VIRUS INFECTION IN B-LYMPHOCYTES (VOL 70, PG 1145, 1996)

      Journal of virology
    45. DEVERGNE O; HUMMEL M; KOEPPEN H; LEBEAU MM; NATHANSON EC; KIEFF E; BIRKENBACH M
      A NOVEL INTERLEUKIN-12 P40-RELATED PROTEIN-INDUCED BY LATENT EPSTEIN-BARR-VIRUS INFECTION IN B-LYMPHOCYTES

      Journal of virology
    46. FRANKEN M; DEVERGNE O; ROSENZWEIG M; ANNIS B; KIEFF E; WANG F
      COMPARATIVE-ANALYSIS IDENTIFIES CONSERVED TUMOR-NECROSIS-FACTOR RECEPTOR-ASSOCIATED FACTOR-3 BINDING-SITES IN THE HUMAN AND SIMIAN EPSTEIN-BARR-VIRUS ONCOGENE LMP1

      Journal of virology
    47. ISHIDA T; MIZUSHIMA S; AZUMA S; KOBAYASHI N; TOJO T; SUZUKI K; AIZAWA S; WATANABE T; MOSIALOS G; KIEFF E; YAMAMOTO T; INOUE J
      IDENTIFICATION OF TRAF6, A NOVEL TUMOR-NECROSIS-FACTOR RECEPTOR-ASSOCIATED FACTOR PROTEIN THAT MEDIATES SIGNALING FROM AN AMINO-TERMINAL DOMAIN OF THE CD40 CYTOPLASMIC REGION

      The Journal of biological chemistry
    48. CHRIST AD; STEVENS C; DEVERGNE O; KOEPPEN H; KIEFF E; BIRKENBACH M; BLUMBERG RS
      A NOVEL, HUMAN IL12 RELATED CYTOKINE IS UP-REGULATED IN THE INTESTINAL-MUCOSA IN INFLAMMATION

      Gastroenterology
    49. MOSIALOS G; BIRKENBACH M; AYEHUNIE S; MATSUMURA F; PINKUS GS; KIEFF E; LANGHOFF E
      CIRCULATING HUMAN DENDRITIC CELLS DIFFERENTIALLY EXPRESS HIGH-LEVELS OF A 55-KD ACTIN-BUNDLING PROTEIN

      The American journal of pathology
    50. MILLER CL; BURKHARDT AL; LEE JH; STEALEY B; LONGNECKER R; BOLEN JB; KIEFF E
      INTEGRAL MEMBRANE-PROTEIN 2 OF EPSTEIN-BARR-VIRUS REGULATES REACTIVATION FROM LATENCY THROUGH DOMINANT-NEGATIVE EFFECTS ON PROTEIN-TYROSINEKINASES

      Immunity
    51. KIEFF E; MOSIALOS G; ROBERTSON E; KAYE K; IZUMI K; YALAMANCHILI R; HARADA S; LIN J; MILLER C
      SIGNAL-TRANSDUCTION AND TRANSCRIPTIONAL REGULATION IN EPSTEIN-BARR-VIRUS TRANSFORMATION OF PRIMARY HUMAN B-LYMPHOCYTES

      AIDS research and human retroviruses
    52. TONG X; DRAPKIN R; YALAMANCHILI R; MOSIALOS G; KIEFF E
      THE EPSTEIN-BARR-VIRUS NUCLEAR-PROTEIN-2 ACIDIC DOMAIN FORMS A COMPLEX WITH A NOVEL CELLULAR COACTIVATOR THAT CAN INTERACT WITH TFIIE

      Molecular and cellular biology
    53. MOSIALOS G; BIRKENBACH M; YALAMANCHILI R; VANARSDALE T; WARE C; KIEFF E
      THE EPSTEIN-BARR-VIRUS TRANSFORMING PROTEIN LMP1 ENGAGES SIGNALING PROTEINS FOR THE TUMOR-NECROSIS-FACTOR RECEPTOR FAMILY

      Cell
    54. KURILLA MG; HEINEMAN T; DAVENPORT LC; KIEFF E; HUTTFLETCHER LM
      A NOVEL EPSTEIN-BARR-VIRUS GLYCOPROTEIN GP150 EXPRESSED FROM THE BDLF3 OPEN READING FRAME

      Virology
    55. KIEFF E
      EPSTEIN-BARR-VIRUS - INCREASING EVIDENCE OF A LINK TO CARCINOMA

      The New England journal of medicine
    56. TONG X; DRAPKIN R; REINBERG D; KIEFF E
      THE 62-KDA AND 80-KDA SUBUNITS OF TRANSCRIPTION FACTOR IIH MEDIATE THE INTERACTION WITH EPSTEIN-BARR-VIRUS NUCLEAR-PROTEIN-2

      Proceedings of the National Academy of Sciences of the United Statesof America
    57. ROBERTSON ES; GROSSMAN S; JOHANNSEN E; MILLER C; LIN J; TOMKINSON B; KIEFF E
      EPSTEIN-BARR-VIRUS NUCLEAR-PROTEIN 3C MODULATES TRANSCRIPTION THROUGHINTERACTION WITH THE SEQUENCE-SPECIFIC DNA-BINDING PROTEIN J-KAPPA

      Journal of virology
    58. KAYE KM; IZUMI KM; MOSIALOS G; KIEFF E
      THE EPSTEIN-BARR-VIRUS LMP1 CYTOPLASMIC CARBOXY-TERMINUS IS ESSENTIALFOR B-LYMPHOCYTE TRANSFORMATION - FIBROBLAST COCULTIVATION COMPLEMENTS A CRITICAL FUNCTION WITHIN THE TERMINAL-155 RESIDUES

      Journal of virology
    59. ROBERTSON E; KIEFF E
      REDUCING THE COMPLEXITY OF THE TRANSFORMING EPSTEIN-BARR-VIRUS GENOMETO 64 KILOBASE PAIRS

      Journal of virology
    60. MANNICK JB; TONG X; HEMNES A; KIEFF E
      THE EPSTEIN-BARR-VIRUS NUCLEAR ANTIGEN LEADER PROTEIN ASSOCIATES WITHHSP72 HSC73/

      Journal of virology
    61. JOHANNSEN E; KOH E; MOSIALOS G; TONG X; KIEFF E; GROSSMAN SR
      EPSTEIN-BARR-VIRUS NUCLEAR-PROTEIN 2 TRANSACTIVATION OF THE LATENT MEMBRANE-PROTEIN-1 PROMOTER IS MEDIATED BY J-KAPPA AND PU1

      Journal of virology
    62. TONG X; WANG F; THUT CJ; KIEFF E
      THE EPSTEIN-BARR-VIRUS NUCLEAR-PROTEIN-2 ACIDIC DOMAIN CAN INTERACT WITH TFIIB, TAF40, AND RPA70 BUT NOT WITH TATA-BINDING PROTEIN

      Journal of virology
    63. KIEFF E
      EPSTEIN-BARR-VIRUS - NEW INSIGHTS

      The Journal of infectious diseases
    64. MILLER CL; LEE JH; KIEFF E; BURKHARDT AL; BOLEN JB; LONGNECKER R
      EPSTEIN-BARR-VIRUS PROTEIN LMP2A REGULATES REACTIVATION FROM LATENCY BY NEGATIVELY REGULATING TYROSINE KINASES INVOLVED IN SIG-MEDIATED SIGNAL-TRANSDUCTION

      Infectious agents and disease
    65. MANNICK JB; ASANO K; IZUMI K; KIEFF E; STAMLER JS
      NITRIC-OXIDE PRODUCED BY HUMAN B-LYMPHOCYTES INHIBITS APOPTOSIS AND EPSTEIN-BARR-VIRUS REACTIVATION

      Cell
    66. ALFIERI C; ALLISON AC; KIEFF E
      EFFECT OF MYCOPHENOLIC-ACID ON EPSTEIN-BARR-VIRUS INFECTION OF HUMAN B-LYMPHOCYTES

      Antimicrobial agents and chemotherapy
    67. YALAMANCHILI R; TONG X; GROSSMAN S; JOHANNSEN E; MOSIALOS G; KIEFF E
      GENETIC AND BIOCHEMICAL-EVIDENCE THAT EBNA-2 INTERACTION WITH A 63-KDA CELLULAR GTG-BINDING PROTEIN IS ESSENTIAL FOR B-LYMPHOCYTE GROWTH TRANSFORMATION BY EBV

      Virology
    68. MILLER CL; LEE JH; KIEFF E; LONGNECKER R
      AN INTEGRAL MEMBRANE-PROTEIN (LMP2) BLOCKS REACTIVATION OF EPSTEIN-BARR-VIRUS FROM LATENCY FOLLOWING SURFACE-IMMUNOGLOBULIN CROSS-LINKING

      Proceedings of the National Academy of Sciences of the United Statesof America
    69. GROSSMAN SR; JOHANNSEN E; TONG X; YALAMANCHILI R; KIEFF E
      THE EPSTEIN-BARR-VIRUS NUCLEAR ANTIGEN-2 TRANSACTIVATOR IS DIRECTED TO RESPONSE ELEMENTS BY THE J-KAPPA RECOMBINATION SIGNAL BINDING-PROTEIN

      Proceedings of the National Academy of Sciences of the United Statesof America
    70. ROBERTSON ES; TOMKINSON B; KIEFF E
      AN EPSTEIN-BARR-VIRUS WITH A 58-KILOBASE-PAIR DELETION THAT INCLUDES BARF0 TRANSFORMS B-LYMPHOCYTES IN-VITRO

      Journal of virology
    71. MOSIALOS G; HANISSIAN SH; JAWAHAR S; VARA L; KIEFF E; CHATILA TA
      A CA2+ CALMODULIN-DEPENDENT PROTEIN-KINASE, CAM KINASE-GR, EXPRESSED AFTER TRANSFORMATION OF PRIMARY HUMAN B-LYMPHOCYTES BY EPSTEIN-BARR-VIRUS (EBV) IS INDUCED BY THE EBV ONCOGENE LMP1/

      Journal of virology
    72. MOSIALOS G; YAMASHIRO S; BAUGHMAN RW; MATSUDAIRA P; VARA L; MATSUMURA F; KIEFF E; BIRKENBACH M
      EPSTEIN-BARR-VIRUS INFECTION INDUCES EXPRESSION IN B-LYMPHOCYTES OF ANOVEL GENE ENCODING AN EVOLUTIONARILY CONSERVED 55-KILODALTON ACTIN-BUNDLING PROTEIN

      Journal of virology
    73. TONG X; YALAMANCHILI R; HARADA S; KIEFF E
      THE EBNA-2 ARGININE-GLYCINE DOMAIN IS CRITICAL BUT NOT ESSENTIAL FOR B-LYMPHOCYTE GROWTH TRANSFORMATION - THE REST OF REGION-3 LACKS ESSENTIAL INTERACTIVE DOMAINS

      Journal of virology
    74. ARGAET VP; SCHMIDT CW; BURROWS SR; SILINS SL; KURILLA MG; DOOLAN DL; SUHRBIER A; MOSS DJ; KIEFF E; SCULLEY TB; MISKO IS
      DOMINANT SELECTION OF AN INVARIANT T-CELL ANTIGEN RECEPTOR IN RESPONSE TO PERSISTENT INFECTION BY EPSTEIN-BARR-VIRUS

      The Journal of experimental medicine
    75. ZHANG Q; BROOKS L; BUSSON P; WANG F; CHARRON D; KIEFF E; RICKINSON AB; TURSZ T
      EPSTEIN-BARR-VIRUS (EBV) LATENT MEMBRANE-PROTEIN-1 INCREASES HLA CLASS-II EXPRESSION IN AN EBV-NEGATIVE B-CELL LINE

      European Journal of Immunology
    76. TOMKINSON B; MARCHINI A; WANG F; MANICK J; LONGNECKER R; COHEN J; LEE W; SWAMINATHAN S; IZUMI K; KAYE K; KIEFF E
      MOLECULAR-GENETIC ANALYSIS OF EPSTEIN-BARR-VIRUS GENES IN LYMPHOCYTE GROWTH TRANSFORMATION

      Journal of acquired immune deficiency syndromes
    77. DURDA PJ; SULLIVAN M; KIEFF E; PEARSON GR; RABIN H
      AN ENZYME-LINKED-IMMUNOSORBENT-ASSAY FOR THE MEASUREMENT OF HUMAN-IGAANTIBODY-RESPONSES TO EPSTEIN-BARR-VIRUS MEMBRANE ANTIGEN

      Intervirology
    78. KAYE KM; IZUMI KM; KIEFF E
      EPSTEIN-BARR-VIRUS LATENT MEMBRANE PROTEIN-1 IS ESSENTIAL FOR B-LYMPHOCYTE GROWTH TRANSFORMATION

      Proceedings of the National Academy of Sciences of the United Statesof America
    79. LONGNECKER R; MILLER CL; TOMKINSON B; MIAO XQ; KIEFF E
      DELETION OF DNA ENCODING THE 1ST 5 TRANSMEMBRANE DOMAINS OF EPSTEIN-BARR-VIRUS LATENT MEMBRANE PROTEIN-2A AND PROTEIN-2B

      Journal of virology
    80. MILLER CL; LONGNECKER R; KIEFF E
      EPSTEIN-BARR-VIRUS LATENT MEMBRANE PROTEIN-2A BLOCKS CALCIUM MOBILIZATION IN B-LYMPHOCYTES

      Journal of virology
    81. TOMKINSON B; ROBERTSON E; YALAMANCHILI R; LONGNECKER R; KIEFF E
      EPSTEIN-BARR-VIRUS RECOMBINANTS FROM OVERLAPPING COSMID FRAGMENTS

      Journal of virology
    82. SWAMINATHAN S; HESSELTON R; SULLIVAN J; KIEFF E
      EPSTEIN-BARR-VIRUS RECOMBINANTS WITH SPECIFICALLY MUTATED BCRF1 GENES

      Journal of virology
    83. KURILLA MG; SWAMINATHAN S; WELSH RM; KIEFF E; BRUTKIEWICZ RR
      EFFECTS OF VIRALLY EXPRESSED INTERLEUKIN-10 ON VACCINIA VIRUS-INFECTION IN MICE

      Journal of virology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/05/20 alle ore 08:05:08